VVM

Versant Venture Management Portfolio holdings

AUM $82.1M
This Quarter Return
+57.05%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$963M
AUM Growth
+$963M
Cap. Flow
+$167M
Cap. Flow %
17.31%
Top 10 Hldgs %
99.63%
Holding
13
New
2
Increased
1
Reduced
4
Closed
1

Top Buys

1
NARI
Inari Medical, Inc. Common Stock
NARI
$201M
2
ALGS icon
Aligos Therapeutics
ALGS
$91M
3
GRTS
Gritstone bio, Inc. Common Stock
GRTS
$5.31M

Top Sells

1
CRSP icon
CRISPR Therapeutics
CRSP
$90.5M
2
ADVM icon
Adverum Biotechnologies
ADVM
$21.7M
3
OCUL icon
Ocular Therapeutix
OCUL
$15.5M
4
APRE icon
Aprea Therapeutics
APRE
$2.11M
5
VANI icon
Vivani Medical
VANI
$484K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$466M 48.34% 3,040,462 -591,194 -16% -$90.5M
NARI
2
DELISTED
Inari Medical, Inc. Common Stock
NARI
$201M 20.83% +2,298,217 New +$201M
ALGS icon
3
Aligos Therapeutics
ALGS
$73.3M
$91M 9.45% +3,292,339 New +$91M
ADVM icon
4
Adverum Biotechnologies
ADVM
$64.6M
$54.2M 5.63% 5,003,892 -2,000,000 -29% -$21.7M
FLXN
5
DELISTED
Flexion Therapeutics, Inc.
FLXN
$44.3M 4.6% 3,842,578 – –
OCUL icon
6
Ocular Therapeutix
OCUL
$2.12B
$30.3M 3.15% 1,465,384 -750,000 -34% -$15.5M
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$2.92B
$28.7M 2.98% 2,030,616 – –
AKRO icon
8
Akero Therapeutics
AKRO
$3.74B
$20.1M 2.08% 777,727 – –
GRTS
9
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$17.5M 1.82% 4,450,638 +1,347,709 +43% +$5.31M
APRE icon
10
Aprea Therapeutics
APRE
$9.09M
$7.02M 0.73% 1,426,328 -427,901 -23% -$2.11M
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
$3.12M 0.32% 543,753 – –
CLVS
12
DELISTED
Clovis Oncology, Inc.
CLVS
$489K 0.05% 101,855 – –
VANI icon
13
Vivani Medical
VANI
$68.1M
– – -561,612 Closed -$484K